Morphine modulates NF kappa B activation in macrophages

Area of Science:

• Immunology
• Neuroscience
• Pharmacology

Background:

• Chronic morphine use impairs immune function, increasing susceptibility to opportunistic infections.
• Macrophages are critical for innate immunity, and understanding morphine's effects on them is vital for treating infections like HIV/AIDS.

Purpose of the Study:

• To investigate how morphine differentially modulates the expression of key macrophage cytokines, IL-6 and TNF-alpha.
• To elucidate the role of the transcription factor NF kappa B in morphine's effects on macrophage cytokine production.

Main Methods:

• Macrophages were stimulated with lipopolysaccharide (LPS) in the presence of varying morphine concentrations (nanomolar and micromolar).
• Expression levels of IL-6 and TNF-alpha were measured.
• Activation of the transcription factor NF kappa B was assessed.
• The effect of naloxone on morphine's actions was evaluated.

Main Results:

• Nanomolar morphine synergized with LPS to augment IL-6 and TNF-alpha secretion.
• Micromolar morphine inhibited LPS-induced IL-6 and TNF-alpha synthesis.
• Low-dose morphine increased NF kappa B activation, while high-dose morphine decreased it.
• The inhibitory effect of high-dose morphine on NF kappa B was not reversed by naloxone.

Conclusions:

• Morphine exhibits dose-dependent modulation of LPS-induced cytokine production in macrophages.
• High-dose morphine's inhibition of NF kappa B activation appears to involve non-classical opioid receptors.
• These findings have implications for managing infections in patients on chronic morphine therapy.